These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 85052)

  • 41. Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis.
    Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
    Pharmacoeconomics; 2000 Nov; 18(5):469-76. PubMed ID: 11151400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse rate of psoriasis worsened by adding steroids to a dithranol regime.
    Seville RH
    Br J Dermatol; 1976 Dec; 95(6):643-6. PubMed ID: 795450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study on the efficacy of a combined treatment of psoriasis with dithranol and UV-B (selective ultraviolet-phototherapy)].
    Elbracht C; Landes E
    Z Hautkr; 1983 Mar; 58(6):387-97. PubMed ID: 6845805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A topical treatment program for psoriasis with low anthralin concentrations.
    Brody I; Johansson A
    J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
    Monastirli A; Georgiou S; Pasmatzi E; Sakkis T; Badavanis G; Drainas D; Sagriotis A; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):246-51. PubMed ID: 12218286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
    Gloor M; Graf R; Wirth H; Landau M
    Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
    Marriott PJ; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():101-6. PubMed ID: 1268069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of the therapeutic effect of dithranol cream 0.1% and 0.25% with that of dithranol stylus 0.1% and 0.2% in the treatment of psoriasis.
    Gisslèn H; Nordin P
    J Int Med Res; 1983; 11(1):46-50. PubMed ID: 6832465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dithranol in a cream preparation: disperse or dissolve?
    Prins M; Swinkels OQ; Bouwhuis S; de Gast MJ; Bouwman-Boer Y; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):273-9. PubMed ID: 10940817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An open, parallel groups, study of the importance of thoroughness of application in the treatment of psoriasis with a dithranol cream (Micanol).
    Mørk NJ; Austad J; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():23-4. PubMed ID: 1585758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reduction of the UV dose in combined dithranol-UV therapy of psoriasis].
    Bárta U; Schaarschmidt H
    Dermatol Monatsschr; 1985; 171(2):91-4. PubMed ID: 3979628
    [No Abstract]   [Full Text] [Related]  

  • 54. Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial.
    McBride SR; Walker P; Reynolds NJ
    Br J Dermatol; 2003 Dec; 149(6):1259-65. PubMed ID: 14674905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of the response of psoriasis to short-term application of anthralin.
    Marsden JR; Coburn PR; Marks J; Shuster S
    Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antipsoriatic effect of dithranol (anthralin). 2].
    Raab W
    Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
    [No Abstract]   [Full Text] [Related]  

  • 57. Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
    de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
    Dermatology; 2010; 220(4):329-32. PubMed ID: 20389024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of a cream containing 0.1% dithranol in a 17% urea base (Psoradrate) with coal tar pomade in the treatment of scalp psoriasis.
    Wright S; Mann RJ
    Clin Exp Dermatol; 1985 Jul; 10(4):375-8. PubMed ID: 3899424
    [No Abstract]   [Full Text] [Related]  

  • 59. The systemic effect of dithranol treatment in psoriasis.
    Goodfield MJ; Hull SM; Cunliffe WJ
    Acta Derm Venereol; 1994 Jul; 74(4):295-7. PubMed ID: 7976091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind comparison of 0.1% dithranol and 17% urea (Psoradrate cream) and 0.25%-dithranol in vanishing cream (Dithrocream) in the treatment of psoriasis.
    Peachey RD; Burton JL
    Clin Exp Dermatol; 1982 Nov; 7(6):625-8. PubMed ID: 6758994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.